NATIONAL BANK OF CANADA /FI/ - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,648
-55.7%
1,0400.0%0.00%
Q2 2023$26,291
-21.4%
1,0400.0%0.00%
Q1 2023$33,467
+74.4%
1,0400.0%0.00%
Q4 2022$19,188
-31.5%
1,0400.0%0.00%
Q3 2022$28,000
+100.0%
1,0400.0%0.00%
Q2 2022$14,000
-30.0%
1,0400.0%0.00%
Q1 2022$20,000
+17.6%
1,0400.0%0.00%
Q4 2021$17,0001,0400.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,415,689$86,106,0006.66%
Evolutionary Tree Capital Management, LLC 176,336$3,439,0002.39%
Essex Woodlands Management, Inc. 457,085$8,913,0002.16%
HealthCor Management, L.P. 1,423,425$27,757,0001.85%
RICE HALL JAMES & ASSOCIATES, LLC 1,112,325$21,690,0000.86%
Waypoint Capital Advisors, LLC 53,989$1,016,0000.60%
Antara Capital LP 679,600$13,252,0000.40%
Rhenman & Partners Asset Management AB 198,358$3,868,0000.38%
Walleye Capital LLC 505,701$9,861,0000.26%
Polar Capital Holdings Plc 2,456,497$47,902,0000.22%
View complete list of REVANCE THERAPEUTICS INC shareholders